The latest numbers are in. Good news and bad news.
Good news is Butterfly smashed the previous highest sales record by a ridiculously wide margin
thanks to Zyre-03, close to 250 million yens for Q3 (10-12/2025) of FY2026. Bad news is production capacity needs another expansion and the last time it happened (
here and
here) sales took a dip.
Needless to say, this came at the expense of ESN. They barely broke even for 2024 (despite strong but stagnant sales that are comparable to 2023) and are again
millions in the red after paying dividends like for 2022. In response,
they are sizing up developing markets such as India and Indonesia. Good luck with the former.